1.
Napoli M, Sitaru S, Budke A, Kammerl A, Querner G, Immler R, Rohwedder I, Seifert S, Ferraro B, Weckbach L, Catz S, Aramini A, Amendola PG, Allegretti M, Bertini R, Pruenster M, Sperandio M. The dual non-competitive CXCR1/2 inhibitor ladarixin impairs neutrophil extravasation without altering intravascular adhesion. Haematologica 2026;111(4):1344-1354; https://doi.org/10.3324/haematol.2025.287877.